Cargando…

The “Square Box”: Therapeutic Equivalence as a Foundation of the WHO Model List of Essential Medicines

Every two years, the World Health Organization (WHO) updates its Model List of Essential Medicines, intended as a guide for countries to adopt or adapt in accordance with local priorities and treatment guidelines, for the development of national essential medicines lists. When more than one therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cappello, Bernadette, Moja, Lorenzo, Figueras, Albert, Magrini, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533616/ https://www.ncbi.nlm.nih.gov/pubmed/33071791 http://dx.doi.org/10.3389/fphar.2020.578000

Ejemplares similares

Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO
por: Piggott, Thomas, et al.
Publicado: (2022)

Assessing the Appropriateness of Formulations on the WHO Model List of Essential Medicines for Children: Development of a Paediatric Quality Target Product Profile Tool
por: Walsh, Jennifer, et al.
Publicado: (2022)

Tough decisions on essential medicines in 2015
por: Magrini, Nicola, et al.
Publicado: (2015)

The 19th EML as a global standard: an innovative approach or just an opportunity for new and effective medicines?
por: Magrini, Nicola, et al.
Publicado: (2015)

Comparison of essential medicines lists in 137 countries
por: Persaud, Nav, et al.
Publicado: (2019)

Back to the ‘essence’ of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines
por: Eniu, Alexandru, et al.
Publicado: (2016)

Revising the WHO Essential Medicines List for paediatric rheumatology
por: Scott, Christiaan, et al.
Publicado: (2021)

Revising the WHO Essential Medicines List for paediatric rheumatology update
por: Slamang, Waheba, et al.
Publicado: (2022)

Monographs for medicines on WHO’s Model List of Essential Medicines
por: Roth, Lukas, et al.
Publicado: (2018)

A comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicines
por: Mustafa, Asma Abubakr, et al.
Publicado: (2010)

Medicines for cancers in children: The WHO model for selection of essential medicines
por: Robertson, Jane, et al.
Publicado: (2015)

Essential medicines for cancer: WHO recommendations and national priorities
por: Robertson, Jane, et al.
Publicado: (2016)

Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists
por: Jarvis, Jordan D., et al.
Publicado: (2019)

Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List
por: Gotham, Dzintars, et al.
Publicado: (2019)

How to improve antibiotic awareness campaigns: findings of a WHO global survey
por: Huttner, Benedikt, et al.
Publicado: (2019)

Comparative Analysis of ADR on China's National Essential Medicines List (2015 Edition) and WHO Model List of Essential Medicines (19th Edition)
por: Zheng, Fangfang, et al.
Publicado: (2018)

Estimated costs of production and potential prices for the WHO Essential Medicines List
por: Hill, Andrew M, et al.
Publicado: (2018)

NOACs Added to WHO’s Essential Medicines List: Recommendations for Future Policy Actions
por: Di Cesare, Mariachiara, et al.
Publicado: (2020)

Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations
por: Todesco, Beatrice, et al.
Publicado: (2023)

Access to Essential Cardiovascular Medicines in Pakistan: A National Survey on the Availability, Price, and Affordability, Using WHO/HAI Methodology
por: Saeed, Amna, et al.
Publicado: (2021)

Using weighted power mean for equivalent square estimation
por: Zhou, Sumin, et al.
Publicado: (2017)

Using the WHO Essential Medicines List to Assess the Appropriateness of Insurance Coverage Decisions: A Case Study of the Croatian National Medicine Reimbursement List
por: Jeličić Kadić, Antonia, et al.
Publicado: (2014)

Paediatric medicine issues and gaps from healthcare workers point of view: survey results and a narrative review from the global accelerator for paediatric formulations project
por: Barbieri, Elisa, et al.
Publicado: (2023)

A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list
por: Naicker, Ian, et al.
Publicado: (2022)

National adaptation and implementation of WHO Model List of Essential Medicines: A qualitative evidence synthesis
por: Peacocke, Elizabeth F., et al.
Publicado: (2022)

Overall survival benefits of cancer drugs in the WHO Model List of Essential Medicines, 2015–2021
por: Zhou, Yue, et al.
Publicado: (2023)

A simple calculation method for determination of equivalent square field
por: Shafiei, Seyed Ali, et al.
Publicado: (2012)

Determination of square equivalent field for rectangular field in electron therapy
por: Tahmasebi Birgani, Mohammad J., et al.
Publicado: (2013)

"slow ejection square setting : check list approach"
por: Cuisinier, G
Publicado: (1974)

Demonstration of Equivalence of Generic Glatiramer Acetate and Copaxone(®)
por: Lipsky, Peter, et al.
Publicado: (2021)

An equivalence approach to the integrative analysis of feature lists
por: Sánchez-Pla, Alex, et al.
Publicado: (2019)

The case for levetiracetam to be included in essential medicine lists
por: Singh, Gagandeep, et al.
Publicado: (2023)

Availability of Authorizations from EMA and FDA for Age-Appropriate Medicines Contained in the WHO Essential Medicines List for Children 2019
por: delMoral-Sanchez, Jose-Manuel, et al.
Publicado: (2020)

Withdrawn medicines included in the essential medicines lists of 136 countries
por: Charles, Onella, et al.
Publicado: (2019)

Biologic medicine inclusion in 138 national essential medicines lists
por: Kraus, Raphaël, et al.
Publicado: (2021)

The WHO list of essential in vitro diagnostics: Development and next steps
por: Moussy, Francis Gabriel, et al.
Publicado: (2018)

Essential tuberculosis medicines and health outcomes in countries with a national essential medicines list
por: Maraj, Darshanand, et al.
Publicado: (2022)

WHO UPDATES ESSENTIAL MEDICINES LIST WITH NEW ADVICE ON USE OF ANTIBIOTICS, AND ADDS MEDICINES FOR HEPATITIS C, HIV, TUBERCULOSIS AND CANCER
Publicado: (2017)

Critical Appraisal of Reimbursement List in Bosnia and Herzegovina
por: Mujkic, Sabina, et al.
Publicado: (2017)

Scientific Foundations for an IUCN Red List of Ecosystems
por: Keith, David A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8eosl1kqanri256bg89r0grc4g